 Co-Diagnostics NASDAQ:CODX Inc announced that CoSara Diagnostics Private Ltd, its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization CDSCO in India to manufacture and sell its SARAQ Hepatitis B HBV Viral Load Kit as an in vitro diagnostic IVD. CoSaras new real-time HBV PCR test is built on the companys patented CoPrimer technology and designed to be used as an aid in assessing response to antiviral treatments in patients diagnosed with HBV, a disease that leads to more than 800,000 deaths per year, according to the World Health Organization. 